Clinical Trials

The diagnosis of a rare neurodegenerative condition often leaves families in a state of profound uncertainty as they navigate a medical landscape with few answers and even fewer treatment options. For David Booth, a retired builder from the United Kingdom, the journey began not with a sudden

Ovarian cancer continues to represent a formidable obstacle in gynecologic oncology, largely because the disease is frequently detected at advanced stages and tends to develop rapid resistance to standard therapeutic interventions. At the core of this malignancy’s formidable resilience is the TP53

For millions of women worldwide, the journey toward an endometriosis diagnosis has historically been a grueling marathon of physical pain and psychological exhaustion, often spanning nearly a decade of clinical uncertainty. This chronic condition occurs when tissue similar to the uterine lining

The persistent burden of sickle cell disease has historically defined the lives of millions through a cycle of debilitating pain and systemic health complications that frequently lead to premature mortality. For decades, the medical community struggled to provide more than palliative care, as the

The landscape of mental health treatment in the United States is currently undergoing a structural transformation that challenges decades of conventional pharmaceutical wisdom. This shift is characterized by the emergence of a dual-track regulatory system, where high-tech clinical research and

The pursuit of a definitive solution for treatment-resistant neurological disorders has reached a critical juncture at the University of Miami Miller School of Medicine through its leadership in the BEAT-MS clinical trial. Formally recognized as the ITN077AI study, this Phase 3 multicenter,